KWM
IBB icon

Keebeck Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Keebeck Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Sell
1,075
-132
-11% -$22.7K 0.02% 455
2026
Q1 		$204K Sell
1,207
-1,575
-57% -$269K 0.02% 403
2025
Q4 		$470K Sell
2,782
-58
-2% -$9.42K 0.05% 232
2025
Q3 		$410K Hold
2,840
– – 0.05% 245
2025
Q2 		$359K Sell
2,840
-798
-22% -$98K 0.05% 255
2025
Q1 		$465K Sell
3,638
-1,664
-31% -$226K 0.07% 175
2024
Q4 		$701K Sell
5,302
-1,000
-16% -$141K 0.1% 146
2024
Q3 		$918K Sell
6,302
-123
-2% -$17.8K 0.13% 137
2024
Q2 		$882K Hold
6,425
– – 0.13% 139
2024
Q1 		$882K Sell
6,425
-124
-2% -$16.9K 0.13% 143
2023
Q4 		$890K Sell
6,549
-1,465
-18% -$179K 0.15% 135
2023
Q3 		$983K Sell
8,014
-9,387
-54% -$1.19M 0.17% 126
2023
Q2 		$2.21M Hold
17,401
– – 0.3% 82
2023
Q1 		$2.25M Sell
17,401
-78
-0.4% -$10.2K 0.36% 69
2022
Q4 		$2.29M Buy
17,479
+57
+0.3% +$7.37K 0.4% 62
2022
Q3 		$2.04M Sell
17,422
-226
-1% -$28.1K 0.39% 61
2022
Q2 		$2.08M Sell
17,648
-3,401
-16% -$404K 0.4% 64
2022
Q1 		$2.74M Sell
21,049
-36
-0.2% -$4.69K 0.45% 49
2021
Q4 		$3.22M Sell
21,085
-73
-0.3% -$11.3K 0.57% 44
2021
Q3 		$3.42M Hold
21,158
– – 0.67% 36
2021
Q2 		$3.46M Buy
21,158
+1,413
+7% +$218K 0.5% 45
2021
Q1 		$2.97M Sell
19,745
-4,217
-18% -$670K 0.46% 43
2020
Q4 		$3.63M Hold
23,962
– – 0.63% 37
2020
Q3 		$3.24M Sell
23,962
-742
-3% -$101K 0.67% 35
2020
Q2 		$3.38M Buy
24,704
+3,465
+16% +$442K 1.07% 21
2020
Q1 		$2.29M Buy
21,239
+1,919
+10% +$221K 0.95% 24
2019
Q4 		$2.33M Buy
+19,320
New +$2.16M 0.74% 31

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Keebeck Wealth Management's IBB Position: Q2 2026 in Review

Keebeck Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 11% in Q2 2026, selling an estimated $22.7K and leaving 1,075 shares worth $204K. The position accounts for 0.02% of the portfolio, ranked #455.

Keebeck Wealth Management first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.63M in Q4 2020. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Keebeck Wealth Management held 1,075 shares of iShares Biotechnology ETF worth $204K as of Q2 2026.
  • Keebeck Wealth Management sold 132 iShares Biotechnology ETF shares in Q2 2026, an estimated $22.7K.
  • iShares Biotechnology ETF made up 0.02% of Keebeck Wealth Management's portfolio in Q2 2026, its #455 holding.
  • Keebeck Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • Keebeck Wealth Management's iShares Biotechnology ETF position peaked at $3.63M in Q4 2020.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Keebeck Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.